Assistant Professor (Tenure Track) in Immunotherapy / Immuno-Oncology at Lund University Lund University in Sweden

Lund University is advertising tenure-track Assistant Professor positions in immunotherapy, immuno-oncology, and cancer immunotherapy within the Programme for Global Excellence in Lund, Sweden.

The post spans several closely related research directions: Immuno-Oncology & Immune Cell Engineering (Faculty of Medicine), Immunotechnology – Cancer Immunotherapy (Faculty of Engineering), and Experimental Cancer Immunotherapy (Translational Cancer Research). The research themes include immune cell engineering, cancer immunology, translational cancer research, and experimental immuno-oncology approaches.

Applicants are expected to hold a PhD and/or MD and to have a strong background in immuno-oncology, immunotherapy, or a related field. The post also emphasizes research excellence and independence. The announcement is aimed at outstanding researchers with interest in cancer immunotherapy.

This is a full-time tenure-track academic appointment. The post mentions an attractive start-up package, but does not describe a scholarship, tuition waiver, or student stipend.

Deadlines listed in the post are: 26 May 2026 for Immunotechnology, 10 June 2026 for Experimental Cancer Immunotherapy, and 30 June 2026 for Immuno-Oncology & Immune Cell Engineering. The latest deadline is used here for the overall post.

Contacts named in the post include Sara Ek, Kristian Pietras, and Filipe Pereira. The application link provided in the post points to Lund University’s Varbi recruitment portal.